Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 5/20 | 0.81 |
| ▸ | CA6 | P23280 | 5/20 | 0.81 |
| ▸ | CA7 | P43166 | 5/20 | 0.81 |
| ▸ | CA9 | Q16790 | 5/20 | 0.81 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.81 |
| ▸ | CA5B | Q9Y2D0 | 5/20 | 0.81 |
| ▸ | CA2 | P00918 | 4/20 | 0.81 |
| ▸ | CA4 | P22748 | 4/20 | 0.81 |
| ▸ | CA5A | P35218 | 4/20 | 0.81 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.81 |
| ▸ | CA3 | P07451 | 3/20 | 0.81 |
| ▸ | F13A1 | P00488 | 2/20 | 0.81 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.81 |
| ▸ | THPO | P40225 | 2/20 | 0.81 |
| ▸ | CA1 | P00915 | 2/20 | 0.81 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.81 |
| ▸ | PKM | P14618 | 1/20 | 0.81 |
| ▸ | TSHR | P16473 | 1/20 | 0.81 |
| ▸ | MTOR | P42345 | 1/20 | 0.81 |
| ▸ | LMNA | P02545 | 3/20 | 0.77 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL817205 | 1.00 | CA12 (0.81) | CA12CA6CA7CA9CA14 | |
| SCHEMBL18700922 | 1.00 | CA12 (0.81) | CA12CA6CA7CA9CA14 | |
| SCHEMBL14030615 | 1.00 | CA12 (0.81) | CA12CA6CA7CA9CA14 | |
| SCHEMBL15306482 | 1.00 | CA12 (0.81) | CA12CA6CA7CA9CA14 | |
| SCHEMBL18784646 | 1.00 | CA12 (0.81) | CA12CA6CA7CA9CA14 | |
| SCHEMBL27516113 | 1.00 | CA12 (0.81) | CA12CA6CA7CA9CA14 | |
| SCHEMBL18496764 | 0.97 | CA12 (0.88) | CA12CA6CA7CA9CA14 | |
| Water SCHEMBL29135283 | 0.97 | CA12 (0.77) | CA12CA6CA7CA9CA14 | |
| Trientine SCHEMBL15016070 | 0.97 | CA12 (0.77) | CA12CA6CA7CA9CA14 | |
| SCHEMBL16281062 | 0.97 | CA12 (0.87) | CA12CA6CA7CA9CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 189 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240207292-A1 | BORONIC ACID COMPOUNDS, COMPOSITIONS AND METHODS | TRUSTEES OF TUFTS COLLEGE | 2024-06-27 | — | — | US | disclosed |
| US-12016922-B2 | Stabilized aqueous antibody compositions | ARECOR LIMITED (GB) | 2024-06-25 | — | — | US | disclosed |
| US-12016913-B2 | Immunogenic compositions and uses thereof | PFIZER INC. (US) | 2024-06-25 | — | — | US | disclosed |
| US-11912114-B2 | Electrochromic sunroof based on all solid-state flexible thin film electrochromic device and methods to fabricate the same | Shenzhen Guangyi Tech Co., Ltd. (CN) | 2024-02-27 | — | — | US | disclosed |
| US-11912950-B2 | Use of nitrogen compounds quaternised with alkylene oxide and hydrocarbyl-substituted polycarboxylic acid as additives in fuels and lubricants | BASF SE (DE) | 2024-02-27 | — | — | US | disclosed |
| US-11872537-B2 | Metal-organic frameworks for carbon dioxide capture | ExxonMobil Technology and Engineering Company (US) | 2024-01-16 | — | — | US | disclosed |
| US-11834607-B2 | Additives for enhanced extraction of bitumen | DOW GLOBAL TECHNOLOGIES LLC (US) | 2023-12-05 | — | — | US | disclosed |
| US-20230381861-A1 | METHOD FOR MANUFACTURING IRON (Fe)-NICKEL (Ni) ALLOY POWDER | SUMITOMO METAL MINING CO., LTD. (JP) | 2023-11-30 | — | — | US | disclosed |
| US-11828685-B2 | Syntactic foams as mechanically-triggered capture vehicles | RESEARCH TRIANGLE INSTITUTE (US) | 2023-11-28 | — | — | US | disclosed |
| US-11820726-B2 | Motuporamine derivatives as antimicrobial agents and antibiotic enhancers against resistant gram-negative bacteria | UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. (US) | 2023-11-21 | — | — | US | disclosed |
| US-20110071059-A1 | FOAMERS FOR DOWNHOLE INJECTION | CHAMPIONX LLC | 2011-03-24 | — | — | US | disclosed |
| US-20110052673-A1 | THERAPEUTIC COMPOSITIONS | SHIRE HUMAN GENETIC THERAPIES, INC. | 2011-03-03 | — | — | US | disclosed |
| US-20110009641-A1 | Amine-containing lipids and uses thereof | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2011-01-13 | — | — | US | disclosed |
| US-20100331234-A1 | AMINOALCOHOL LIPIDOIDS AND USES THEREOF | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2010-12-30 | — | — | US | disclosed |
| US-20100029991-A1 | METHOD FOR PRODUCING TRIETHYLENETETRAMINE | BASF SE (DE) | 2010-02-04 | — | — | US | disclosed |
| EP-0912584-B1 | NEW BIS-PLATINUM COMPLEXES WITH POLYAMINE LIGANDS AS ANTITUMOR AGENTS | HOFFMANN LA ROCHE (CH) | 2002-12-18 | — | — | EP | disclosed |
| US-6022892-A | Bis-platinum complexes with polyamine ligands as antitumor agents | HOFFMAN-LA ROCHE INC. (US) | 2000-02-08 | — | — | US | disclosed |
| EP-0912584-A2 | NEW BIS-PLATINUM COMPLEXES WITH POLYAMINE LIGANDS AS ANTITUMOR AGENTS | F. HOFFMANN-LA ROCHE AG (CH) | 1999-05-06 | — | — | EP | disclosed |
| WO-1998003519-A9 | NEW BIS-PLATINUM COMPLEXES WITH POLYAMINE LIGANDS AS ANTITUMOR AGENTS | — | 1998-07-16 | — | — | WO | disclosed |
| WO-1998003519-A2 | NEW BIS-PLATINUM COMPLEXES WITH POLYAMINE LIGANDS AS ANTITUMOR AGENTS | F. HOFFMANN-LA ROCHE AG (CH) | 1998-01-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11820726-B2 | Motuporamine derivatives as antimicrobial agents and antibiotic enhancers against resistant gram-negative bacteria | MGAM, PGLS, NISCH | CA12 4851/4885CA6 4102/4885CA7 4347/4885 |
| US-20110052673-A1 | THERAPEUTIC COMPOSITIONS | PHOSPHO1, SGMS1, APOB | CA12 1652/4885CA6 1373/4885CA7 2764/4885 |
| US-20110009641-A1 | Amine-containing lipids and uses thereof | PHOSPHO1, CHMP4B, SGMS1 | CA12 4058/4885CA6 1593/4885CA7 2387/4885 |
| US-20100029991-A1 | METHOD FOR PRODUCING TRIETHYLENETETRAMINE | TET1, TET3, TET2 | CA12 2019/4885CA6 1770/4885CA7 2066/4885 |
| US-11872537-B2 | Metal-organic frameworks for carbon dioxide capture | MT-CO2, TMCO1, SLC6A12 | CA12 13/4885CA6 81/4885CA7 60/4885 |
| US-11912950-B2 | Use of nitrogen compounds quaternised with alkylene oxide and hydrocarbyl-substituted polycarboxylic acid as additives in fuels and lubricants | DGKI, DERL1, DEK | CA12 1074/4885CA6 1114/4885CA7 2072/4885 |
| US-12016913-B2 | Immunogenic compositions and uses thereof | FCGR3B, SIGLEC7, SIGLEC9 | CA12 139/4885CA6 413/4885CA7 213/4885 |
| US-20240207292-A1 | BORONIC ACID COMPOUNDS, COMPOSITIONS AND METHODS | BCL6B, BCL6, BTD | CA12 95/4885CA6 20/4885CA7 38/4885 |
| US-12016922-B2 | Stabilized aqueous antibody compositions | IGLV6-57, FCGRT, PA2G4 | CA12 737/4885CA6 3843/4885CA7 3689/4885 |
| US-20100331234-A1 | AMINOALCOHOL LIPIDOIDS AND USES THEREOF | PHOSPHO1, PNMT, AASDHPPT | CA12 4669/4885CA6 4444/4885CA7 4866/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.